Publication|Articles|August 1, 1996

July/August 1996
Volume 2
Issue 7

Understanding the Behavioral Response to Medical Innovation

Author(s)A. Mark Fendrick, MD, Michael E. Chernew, PhD, Richard Hirth, PhD

Download PDF: Understanding the Behavioral Response to Medical Innovation

Articles in this issue

about 30 years ago

Article

Correspondence regarding, "Intended and Unintended Consequences of HMO Cost-Containment Strategies: Results from the Managed Care Outcomes Project"

about 30 years ago

Article

Correspondence regarding, "Ethics in Managed Care: The Obligation of Administration to Attending Consequences"

about 30 years ago

Article

Process and Outcome of Outpatient Management of Heart Failure: A Comparison of Cardiologists and Primary Care Providers

about 30 years ago

Article

Cost Comparison of Induction of Labor Versus Expectant Management in Pregnancies Lasting Longer Than 41 Weeks

about 30 years ago

Article

Respiratory Syncytial Virus Immune Globulin: A Cost-Effectiveness Analysis

about 30 years ago

Article

Improving Patient Satisfaction with Warfarin Management

about 30 years ago

Article

The Third Generation of Managed Care

about 30 years ago

Article

Results of a Smoking-Cessation Program in a Managed Care Setting

about 30 years ago

Article

Breast Cancer Screening: Who, When, and How

about 30 years ago

Article

Formulary Decision-Making for Evolving Therapies -- A Case Example: Fluticasone and Asthma

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

ByAayush Sisodia, MSHI, BDS

Published: August 6th 2026 | Updated: August 31st 2026

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

ByThomas W. Martens, MD,Bimal V. Patel, PharmD, MS,Sharon M. Wang, PharmD, MS,Laurel H. Messer, PhD, MPH, RN, CDCES, BC-ADM,Jordan E. Pinsker, MD,Daniel C. Malone, PhD, RPh,Miranda R. Polin, MS, BS,Diana I. Brixner, PhD, RPh,Diana Isaacs, PharmD, BCPS, BCACP, BC-ADM, CDCES,Osagie Ebekozien, MD, MPH

July 23rd 2026

Geographical Access to Preferred Pharmacies in Medicare Part D

ByPinka Chatterji, PhD,Yiran Han, PhD,Chun-Yu Ho, PhD

July 22nd 2026

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

ByEmily A. Gadbois, PhD,Jennifer Bunker, MPH,Marguerite Daus, PhD, RN,Jamie M. Smith, PhD, RN,Emily Buss, MSN, RN,Christine D. Jones, MD, MS,Kali S. Thomas, PhD, MA

July 16th 2026

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

ByHeather L. Taylor, MPH, LDH,Ann M. Holmes, PhD,Nir Menachemi, PhD, MPH,Justin Blackburn, PhD

July 10th 2026

Understanding the Behavioral Response to Medical Innovation

Articles in this issue

Related Content

Predicting GLP-1 Discontinuation From Pharmacy Claims

Impact of Automated Insulin Delivery on Type 2 Diabetes Measures

Geographical Access to Preferred Pharmacies in Medicare Part D

Roles and Priorities Guiding Medicare Advantage Postacute Home Health Referrals

Reply to Letter Regarding “Preventive Dental Care and Overall Medical Expenditures”

Trending on AJMC

5 Things to Know About the FDA's Peptide Reversal

Moderna, Merck mRNA Cancer Vaccine Succeeds in Late-Stage Trial

FDA Approves First Orexin Agonist for Narcolepsy Type 1

Ochsner Health, Paradigm Health Partnership Expands Clinical Trial Access Across the Gulf South

Vutrisiran Associated With Slower Decline in Left Atrial Function in ATTR-CM